1. Academic Validation
  2. Network pharmacology, molecular docking and experimental study on the mechanism of Curcumin's anti-ferroptosis in melanocytes

Network pharmacology, molecular docking and experimental study on the mechanism of Curcumin's anti-ferroptosis in melanocytes

  • Biochem Biophys Res Commun. 2024 Dec 3:736:150871. doi: 10.1016/j.bbrc.2024.150871.
Lyu-Ye Liu 1 Si-Jia He 2 Jing Luo 3 Jun-Kai Huang 3 Jin-Xiang Yuan 1 Chuan-Jian Yuan 1 Jun-Ling Zhang 4
Affiliations

Affiliations

  • 1 Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, 300000, China.
  • 2 Department of Dermatology, Tianjin Public Security Hospital, Tianjin, 300000, China.
  • 3 Department of Pathogen Biology and Immunology, Basic Medical College, Tianjin Medical University, Tianjin, 300000, China.
  • 4 Department of Dermatology, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, 300000, China. Electronic address: zhangjunlingtj@126.com.
Abstract

Ferroptosis is a form of regulated nonapoptotic cell death associated with iron-dependent lipid peroxidation, closely associated with Vitiligo. Although the impact of Curcumin (Cur), a polyphenolic compound derived from the plant Curcuma longa Linn, on vitiligo has been established, the specific role and potential mechanistic pathways through which Cur modulates Ferroptosis in vitiligo remain elusive. In this study, the critical targets and potential mechanisms of Cur in treating vitiligo were predicted by network pharmacology and molecule docking. Then, the effects of Cur on Erastin-induced Ferroptosis were investigated in melanocytes induced by Erastin in vitro. The Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis of Cur acting on Vitiligo found that these intersection genes are associated with the vitiligo oxidative stress pathway, including nuclear factor erythroid 2-related factor 2(Nrf2)/Heme Oxygenase 1(HO-1) signaling pathway. Further molecular docking shows that Cur has a good binding effect with Nrf2(the binding energy of Cur and Nrf2 protein is -6 kcal/mol). Through the CCK8 assay, showed that 10 μM Cur treatment 24 h after Erastin significantly improved cell viability In vitro. Then we found that Erastin induced cell death, ROS production, the mitochondrial membrane potential(MMP) decreased, Superoxide dismutase (SOD) and Glutathione (GSH) levels reduced, Malonaldehyde (MDA) and iron ion accumulation in melanocytes. In addition, the expression of Glutathione Peroxidase 4(GPX4) mRNA and protein was inhibited, while the expression of acyl-CoA synthetase long-chain family member 4(ACSL4), Transferrin Receptor Protein 1(TFR1) mRNA and protein was increased. However, the damage induced by Erastin was significantly relieved by Cur and Fer-1 treatment. Mechanistically, Cur treatment significantly promoted nuclear translocation of transcriptional factor Nrf2 and HO-1 expression. Interestingly, pretreatment with ML385, a selective Nrf2 inhibitor, counteracted anti-ferroptosis effects induced by Cur treatment. Taken together, these results demonstrate that Cur inhibits Ferroptosis by regulating the Nrf2/HO-1 pathway to protect melanocytes.

Keywords

Curcumin; Ferroptosis; Heme Oxygenase-1; Melanocytes; Nuclear factor erythrocyte-2-associated factor 2.

Figures
Products